SCHEMBL5352719

SCHEMBL5352719

COS(=O)(=O)[O-].C[N+]1(CCO)CCN(c2ccc([N+](=O)[O-])cc2)CC1

nearest known ligand 0.50

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.44
MAPT P10636 10/20 0.50
ALDH1A1 P00352 6/20 0.46
HTT P42858 1/20 0.46
TP53 P04637 1/20 0.46
LMNA P02545 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
SIRT6 Q8N6T7 2/20 0.45
BCHE P06276 1/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.42
ADRB1 P08588 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6746535 0.91 SIRT6 (0.54) MAPTALDH1A1HTTTP53LMNA
Hydrochloric Acid SCHEMBL5364983 0.89 SIRT6 (0.52) MAPTALDH1A1HTTTP53LMNA
SCHEMBL5357980 0.84 SIRT6 (0.52) MAPTALDH1A1LMNASMN1; SMN2SIRT6
SCHEMBL5393424 0.80 MAPT (0.54) MAPTALDH1A1LMNASMN1; SMN2SIRT6
SCHEMBL5357616 0.73 SIRT6 (0.65) MAPTALDH1A1LMNASMN1; SMN2SIRT6
Hydrochloric Acid SCHEMBL5352144 0.72 SIRT6 (0.63) MAPTALDH1A1LMNASMN1; SMN2SIRT6
SCHEMBL5351218 0.70 MAPT (0.47) MAPTALDH1A1HTTTP53LMNA
Hydrochloric Acid SCHEMBL5349721 0.69 MAPT (0.46) MAPTALDH1A1HTTTP53LMNA
Hydrochloric Acid SCHEMBL5358867 0.68 MAPT (0.46) MAPTALDH1A1HTTTP53LMNA
SCHEMBL6748663 0.68 MAPT (0.66) MAPTALDH1A1LMNASMN1; SMN2SIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7186277-B2 Composition for dyeing keratin fibres, comprising a cationic para-phenylenediamine derivative substituted with a diazacyclohexane or diazacycloheptane ring L'OREAL SA (FR) 2007-03-06 US disclosed
US-20040237216-A1 Composition for dyeing keratin fibres, comprising a cationic para-phenylenediamine derivative substituted with a diazacyclohexane or diazacycloheptane ring L'OREAL S.A. (FR) 2004-12-02 US disclosed
EP-1462091-A1 Composition for dyeing of keratinic fibers comprising a cationic derivative of p-phenylenediamine substituted by a diazacyclohexane or a diazacyloheptane L'OREAL (FR) 2004-09-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040237216-A1 Composition for dyeing keratin fibres, comprising a cationic para-phenylenediamine derivative substituted with a diazacyclohexane or diazacycloheptane ring KRT18, CDC73, DSP ACHE 1016/4885MAPT 2272/4885ALDH1A1 1421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.